|
In the Asthma Drug Market, Generic Erosion Will Reduce Sales of Merck/Kyorin's …
MarketWatch (press release) The upcoming Pharmacor advisory service entitled Asthma, which will be published soon, also finds that the overall market for asthma therapies will be relatively flat over the next decade, with sales increasing slightly by approximately $200 million … |
View full post on asthma – Google News